Staff

Dr. V. Schulze Greiving (Stimberg)

Postdoctoral Researcher
Ravelijn room RA 4333

Adress
Dr. Verena Schulze Greiving (Stimberg)
MB-STePS
PO Box 217
NL - 7500 AE Enschede

E-mail: v.c.schulzegreiving (at) utwente.nl
Telephone: (053) 489 4248
Fax: (053) 489 2159

Background

Verena Schulze Greiving studied Chemistry at the University of Applied Sciences (Saxion Hogeschool, Enschede) followed by the MSc program Nanotechnology at the University of Twente, Enschede. In September 2010 she started as a PhD student in the BIOS – Lab on a chip group at the same university to develop a microfluidic platform for experimentation on bilayer lipid membranes. In the frame of this NanoNextNL PhD project, Verena Schulze Greiving co-organized a constructive technology assessment (CTA) workshop which resulted in a complete chapter in her thesis. She continued her TA excursion in the frame of a NanoNextNL PostDoc project at STePS, where she created an overview of various CTA methods towards a sort of ‘toolbox which is available online at www.cta-toolbox.nl. Currently, Verena is involved in the “Digitalize or Die” project in which she analyzes which role Responsible Research and Innovation plays in ICT-based Health Care Technologies in Twente and the region Overijssel.

Publications

Journal articles

  • Schulze Greiving and Konrad, Society is part of the equation, Nature Nanotechnology, 2017, 12, 184. Read online.
  • Stimberg et al., High Yield, Reproducible and Quasi-Automated Bilayer Formation in a Microfluidic Format, 2013, Small, 9, 7, 1076–1085. Cover article.

Book chapters

  • Schulze Greiving et al., ‘CTA-lite’ for exploring possible innovation pathways of a nanomedicine-related platform – embedded Responsible Research and Innovation in practice, In: DM Bowman, A Dijkstra, C Fautz, J Guivant, K Konrad, H van Lente and S Woll (eds), Responsibility and Emerging Technologies: Experiences, Education and Beyond, Berlin: AKA Press, 25-42, 2016. Read as pdf.
  • Fisher et al., Building an Agenda for Socio-Technical Integration Approaches, In: DM Bowman, A Dijkstra, C Fautz, J Guivant, K Konrad, H van Lente and S Woll (eds), Responsibility and Emerging Technologies: Experiences, Education and Beyond, Berlin: AKA Press, 43-56, 2016.

Official reports

  • Schulze Greiving et al., Nanotechnologie in dienst van veiligheid en justitie, Commissioned study of the Research and Documentation Centre (Dutch Ministry of Security and Justice), October 2016. Read as pdf.

Peer-reviewed conference proceedings

  • Stimberg et al., Simultaneous confocal and electrophysiological assessment of membrane properties and ion channel activity in a microfluidic format – a powerful combination for drug development. Proceedings of MicroTAS 2014, San Antonio (TX, USA).
  • Prokofyev et al., Multiplexed microfluidic platform for electrophysiological measurements on ion channels in a functional environment. Proceedings of MicroTAS 2014, San Antonio (TX, USA).
  • Stimberg et al., BLM experimentation and opto-electrical characterization in microchips. Towards an integrated platform for drug screening on membrane proteins. Proceedings of MicroTAS 2010, Groningen (The Netherlands), 830-832.
  • Stimberg et al., Integrated microfluidic platform for fundamental bilayer studies and experimentation on single pore-forming species. Proceedings of MicroTAS 2011, Seattle (WA, USA), 1400-1402.

Oral presentations

  • Lessons learned: Responsible Research and Innovation at the Lab Floor. 4S/EASST conference, Barcelona (Spain), 31 August – 3 September 2016.
  • Towards a technology assessment toolbox to support responsible research and innovation at the workfloor. S.NET conference 2015, Montreal (Canada), 18-21 October 2015.
  • Towards a technology assessment toolbox. Nanocity 2015, Amersfoort (The Netherlands), 5-6 October 2015.
  • Studying the impact of membrane properties on ion channel activity in a microfluidic format – an important aspect in drug development. NanoBio-Europe 2014, Münster (NRW, Germany), 2-4 June 2014.
  • Multiplexed Microfluidic Device for Bilayer Experimentation and Drug Screening Assays on Membrane Proteins. 56th Annual Meeting of the Biophysical Society 2012, San Diego (CA, USA), 25-29 February 2012.
  • Integrated microfluidic platform for studies on membrane proteins and drug screening assays, MicroNano conference 2011, Epe (The Netherlands), 15-16 November 2011.
  • Integrated microfluidic platform for fundamental bilayer studies and experimentation on single pore-forming species. MicroTAS 2011, Seattle (WA, USA), 2-6 October 2011.
  • Integrated microfluidic platform for studies on membrane proteins and drug screening assays. 55th Annual Meeting of the Biophysical Society 2011, Baltimore (MD, USA), 5-9 March 2011.
  • BLM experimentation and opto-electrical characterization in microchips. Towards an integrated platform for drug screening on membrane proteins. NanoBioTech, Montreux (Switzerland), 15-17 November 2010.

Invited lectures

  • Nanotechnologie in dienst van veiligheid en justitie. Innovation network meeting of the Dutch Ministry of Security and Justice, Den Hague (The Netherlands), 21 September 2016.
  • A Toolbox to Support Responsible Research and Innovation at the Lab Floor. STePS-Seminar, University of Twente (The Netherlands), 14 September 2016.
  • Exploring innovation pathways for nanomedicine platforms. Presentation at the NanoNextNL Board Meeting for the midterm review, Utrecht (The Netherlands), 13 March 2014.
  • Microfluidic platform for bilayer experimentation - Application to monitor membrane dynamics using confocal microscopy combined with electrophysiological measurements of gramicidin activity. SRO meeting Nanomedicine, MESA+, University of Twente (The Netherlands), 16 January 2014.
  • Microfluidic platform for bilayer experimentation and drug screening on membrane proteins. Presentation for the NanoNextNL Supervisory Board Meeting, Utrecht (The Netherlands), 20 November 2013.
  • Versatile microfluidic platform for bilayer experimentation. SRO meeting Enabling Technologies, MESA+, University of Twente (The Netherlands), 10 April 2013.
  • Microfluidic platform for drug screening on membrane proteins. Journal club presentation, visiting the lab of Prof. Michael Fill and Dr. Dirk Gillespie. Rush University Medical Center, Chicago (IL, USA), 10 October 2011.
  • Integrated microfluidic platform for bilayer studies and experimentation on single pore-forming species. MESA+ day, University of Twente (The Netherlands), 27 September 2011.

Posters

  • Are existing technology assessment methods suitable for integrating RATA in research projects? Nanocity 2016, Amsterdam (The Netherlands), 21 June 2016.
  • How to use technology assessment to add an extra dimension to your research? Nanocity 2015, Amersfoort (The Netherlands), 5-6 October 2015.
  • Studying the impact of membrane properties on ion channel activity in a microfluidic format– an important aspect in drug development. Nanocity 2014, Utrecht (The Netherlands), 27-28 October 2014.
  • Pre-screening tool to define promising applications for possible commercialization. Nanocity 2014, Utrecht (The Netherlands), 27-28 October 2014.
  • Probing Simultaneously Membrane Dynamics and Protein Activity in Suspended Bilayers in a Microfluidic Format. 58th Annual Meeting of the Biophysical Society 2014, San Francisco (CA, USA), 15-19 February 2014.
  • Integrated microfluidic platform for fundamental bilayer studies and experimentation on single pore-forming species. Dutch meeting on Molecular and Cellular Biophysics, Veldhoven (The Netherlands), 1-2 October 2012.
  • BLM experimentation and opto-electrical characterization in microchips.
  • Towards an integrated platform for drug screening on membrane proteins. NanoBioTech, Montreux (Switzerland), 14-16 November 2011.
  • BLM experimentation and opto-electrical characterization in microchips. Towards an integrated platform for drug screening on membrane proteins. MicroTAS 2010, Groningen (The Netherlands), 3-7 October 2010.